FSI
PBMWW

Flow State Investments’s Psyence Biomedical Warrant PBMWW Stock Holding History

Flow State Investments’s Portfolio PBMWW Stock Details PBMWW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-55,000
Closed -$578 – 125
2024
Q2 		$578 Hold
55,000
– – ﹤0.01% 207
2024
Q1 		$3.85K Buy
+55,000
New +$3.43K ﹤0.01% 203

Other funds holding PBMWW

CAC
Cowen and Company New York $2.97B AUM 105.26% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.27% 1-Year Est. Return
MI
MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return
Calamos Advisors
Calamos Advisors Naperville, Illinois $28.2B AUM 21.78% 1-Year Est. Return
CF
Cantor Fitzgerald New York $6.78B AUM 29.01% 1-Year Est. Return
SCM
Saba Capital Management New York $3.62B AUM 13% 1-Year Est. Return
CSD
Clear Street Derivatives New York $12.4M AUM 1.7% 1-Year Est. Return
AC
Aristeia Capital Greenwich, Connecticut $4.82B AUM 24.94% 1-Year Est. Return
CCM
Context Capital Management Lajolla, California $4.33B AUM 1.35% 1-Year Est. Return
PC
Periscope Capital Toronto, Ontario, Canada $902M AUM 6.51% 1-Year Est. Return

Flow State Investments's PBMWW Position: Q3 2024 in Review

Flow State Investments sold out of Psyence Biomedical Warrant (PBMWW) in Q3 2024, closing a stake of 55,000 shares — an estimated $578 sold.

Flow State Investments first reported a position in PBMWW in Q1 2024 and held it in 2 quarters. The position peaked at $3.85K in Q1 2024. 23 funds tracked by Wall St. Rank hold PBMWW as of Q3 2024.

  • Flow State Investments reported no remaining Psyence Biomedical Warrant position as of Q3 2024 after selling out during the quarter.
  • Flow State Investments sold 55,000 Psyence Biomedical Warrant shares in Q3 2024, an estimated $578.
  • Flow State Investments first reported a position in Psyence Biomedical Warrant in Q1 2024 and held it in 2 quarters.
  • Flow State Investments's Psyence Biomedical Warrant position peaked at $3.85K in Q1 2024.
  • 23 funds tracked by Wall St. Rank held Psyence Biomedical Warrant as of Q3 2024.

Based on Flow State Investments's 13F filing for Q3 2024, filed 14 Nov 2024.